Bright Minds Biosciences Inc. (DRUG) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Total Current Assets | 312.07M | 90.79M | 84.31M | 52.37M | 56.31M | 58.22M | 5.99M | 6.27M | 6.5M | 6.84M | 6.81M | 8.38M | 9.88M | 11.43M | 11.95M | 8.82M | 11.76M | 15.41M | 20.04M | 22.21M |
| Cash & Short-Term Investments | 309.47M | 89.05M | 82.91M | 51.39M | 55.68M | 57.9M | 5.72M | 6.19M | 5.93M | 6.76M | 6.75M | 8.13M | 9.67M | 11.21M | 11.63M | 8.64M | 11.47M | 15.12M | 19.76M | 22.01M |
| Cash Only | 309.3M | 89.05M | 82.91M | 51.39M | 55.68M | 57.9M | 5.72M | 6.19M | 5.93M | 6.76M | 6.75M | 8.13M | 9.67M | 11.21M | 11.63M | 8.64M | 11.47M | 15.12M | 19.76M | 22.01M |
| Short-Term Investments | 172.38K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.14M | 502.68K | 413.07K | 272.63K | 233.57K | 67.02K | 50.22K | 17.24K | 553.25K | 45.04K | 36.98K | 103.68K | 33.36K | 59.27K | 155.78K | 96.44K | 208.4K | 149.69K | 110.15K | 77.98K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 72.33K | 92.18K | 111.97K | 128.98K | 154.51K | 176.99K | 117.66K | 12.07K | 30.19K | 48.3K | 66.41K | 84.53K | 102.64K | 120.75K | 138.86K | 2K | 2K | 2K | 2K | 2K |
| Property, Plant & Equipment | 72.33K | 92.18K | 111.97K | 128.98K | 154.51K | 176.99K | 117.66K | 12.07K | 30.19K | 48.3K | 66.41K | 84.53K | 102.64K | 120.75K | 138.86K | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 2K | 2K | 2K | 2K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.68K | 33.68K | 33.68K |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -33.68K | -33.68K | -33.68K |
| Total Assets | 312.15M | 90.88M | 84.42M | 52.5M | 56.47M | 58.4M | 6.1M | 6.28M | 6.53M | 6.89M | 6.88M | 8.46M | 9.99M | 11.55M | 12.09M | 8.82M | 11.76M | 15.41M | 20.04M | 22.22M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 452.77% | 55.62% | 1282.92% | 736.23% | 764.61% | 747.95% | -11.26% | -25.8% | -34.6% | -40.37% | -43.09% | -4.07% | -15.1% | -25.06% | -39.69% | -60.3% | -54.3% | 605.7% | 2176.76% | - |
| Total Current Liabilities | 3.83M | 1.58M | 2.34M | 604.99K | 637.97K | 461.52K | 528.68K | 178.63K | 845.79K | 854.16K | 280.86K | 720.8K | 1.01M | 528.1K | 1.47M | 385.32K | 1M | 489.6K | 638.57K | 322.86K |
| Accounts Payable | 3.63M | 1.43M | 1.71M | 510.8K | 551.22K | 373.63K | 407.55K | 149.61K | 801.05K | 799.6K | 182.31K | 643.4K | 247.95K | 322.17K | 1.25M | 385.32K | 994.82K | 482.6K | 596.57K | 322.86K |
| Days Payables Outstanding | 11.31K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | -2.69K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 81.48x | 57.37x | 36.10x | 86.56x | 88.27x | 126.15x | 11.32x | 35.08x | 7.69x | 8.01x | 24.26x | 11.62x | 9.83x | 21.64x | 8.11x | 22.88x | 11.72x | 31.48x | 31.38x | 68.80x |
| Quick Ratio | 81.48x | 57.37x | 36.10x | 86.56x | 88.27x | 126.15x | 11.32x | 35.08x | 7.69x | 8.01x | 24.26x | 11.62x | 9.83x | 21.64x | 8.11x | 22.88x | 11.72x | 31.48x | 31.38x | 68.80x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 16.74K | 41.25K | 62.84K | 88.85K | 110.07K | 39.58K | 0 | 0 | 0 | 0 | 14.02K | 34.73K | 54.56K | 71.98K | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 16.74K | 41.25K | 62.84K | 88.85K | 110.07K | 39.58K | 0 | 0 | 0 | 0 | 14.02K | 34.73K | 54.56K | 71.98K | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3.83M | 1.6M | 2.38M | 667.83K | 726.81K | 571.59K | 568.26K | 178.63K | 845.79K | 854.16K | 280.86K | 734.81K | 1.04M | 582.66K | 1.54M | 385.32K | 1M | 489.6K | 638.57K | 322.86K |
| Total Debt | 82.07K | 104.9K | 125.78K | 141.03K | 166.6K | 182.73K | 118.96K | 14.02K | 34.73K | 54.56K | 73.55K | 91.41K | 108.32K | 124.48K | 139.91K | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -309.22M | -88.94M | -82.78M | -51.25M | -55.51M | -57.71M | -5.6M | -6.18M | -5.9M | -6.71M | -6.67M | -8.04M | -9.56M | -11.09M | -11.49M | -8.64M | -11.47M | -15.12M | -19.76M | -22.01M |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.02x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | 0.06x | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | -24.43x | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -2784.18x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 308.32M | 89.28M | 82.04M | 51.83M | 55.74M | 57.83M | 5.54M | 6.1M | 5.69M | 6.03M | 6.6M | 7.73M | 8.95M | 10.97M | 10.54M | 8.43M | 10.76M | 14.92M | 19.4M | 21.89M |
| Equity Growth % | 453.11% | 54.39% | 1381.93% | 749.77% | 880.45% | 858.53% | -16.09% | -21.05% | -36.45% | -44.99% | -37.41% | -8.4% | -16.85% | -26.51% | -45.66% | -61.47% | -57.52% | 614.49% | 2560.36% | - |
| Book Value per Share | 32.15 | 11.50 | 11.45 | 7.32 | 11.99 | 12.44 | 1.19 | 1.31 | 1.27 | 1.57 | 1.75 | 2.05 | 2.36 | 3.06 | 3.53 | 3.55 | 4.54 | 6.30 | 8.20 | 9.67 |
| Total Shareholders' Equity | 308.32M | 89.28M | 82.04M | 51.83M | 55.74M | 57.83M | 5.54M | 6.1M | 5.69M | 6.03M | 6.6M | 7.73M | 8.95M | 10.97M | 10.54M | 8.43M | 10.76M | 14.92M | 19.4M | 21.89M |
| Common Stock | 365.52M | 136.77M | 123.25M | 89.91M | 89.89M | 89.02M | 35.42M | 35.05M | 35.05M | 35.05M | 33.91M | 33.91M | 33.91M | 33.68M | 32.24M | 27.19M | 27.17M | 27.18M | 27.08M | 27.05M |
| Retained Earnings | -64.56M | -54.14M | -46.58M | -42.49M | -37.25M | -34.3M | -34.35M | -33.58M | -33.81M | -33.23M | -31.55M | -30.02M | -28.56M | -26.51M | -24.17M | -21.21M | -18.56M | -14.07M | -9.21M | -6.34M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 7.35M | 6.65M | 5.37M | 4.41M | 3.1M | 3.11M | 4.01M | 3.8M | 3.61M | 3.39M | 3.4M | 3M | 2.76M | 2.96M | 2.48M | 2.45M | 2.15M | 1.85M | 1.57M | 1.22M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |